{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:45:14Z","timestamp":1791312314670,"version":"4.3.1"},"reference-count":62,"publisher":"American Institute of Mathematical Sciences (AIMS)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MBE"],"published-print":{"date-parts":[[2026]]},"DOI":"10.3934\/mbe.2026052","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T10:37:51Z","timestamp":1776076671000},"page":"1402-1436","source":"Crossref","is-referenced-by-count":1,"title":["A stochastic agent-based model for simulating tumor\u2013immune dynamics and evaluating therapeutic strategies"],"prefix":"10.3934","volume":"23","author":[{"given":"Yuhong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"School of Software, Tiangong University, Tianjin 300387, China","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"School of Mathematical Sciences, Tiangong University, Tianjin 300387, China","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Center for Applied Mathematics, Tiangong University, Tianjin 300387, China","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2321","reference":[{"key":"key-10.3934\/mbe.2026052-1","doi-asserted-by":"publisher","unstructured":"T. F. Gajewski, H. Schreiber, Y. X. Fu, Innate and adaptive immune cells in the tumor microenvironment, <i>Nat. Immunol.<\/i>, <b>14<\/b> (2013), 1014\u20131022. https:\/\/doi.org\/10.1038\/ni.2703","DOI":"10.1038\/ni.2703"},{"key":"key-10.3934\/mbe.2026052-2","doi-asserted-by":"publisher","unstructured":"M. S. Paul, P. S. Ohashi, The roles of CD8(+) T cell subsets in antitumor immunity, <i>Trends Cell Biol.<\/i>, <b>30<\/b> (2020), 695\u2013704. https:\/\/doi.org\/10.1016\/j.tcb.2020.06.003","DOI":"10.1016\/j.tcb.2020.06.003"},{"key":"key-10.3934\/mbe.2026052-3","doi-asserted-by":"publisher","unstructured":"K. E. de Visser, J. A. Joyce, The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth, <i>Cancer Cell<\/i>, <b>41<\/b> (2023), 374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016","DOI":"10.1016\/j.ccell.2023.02.016"},{"key":"key-10.3934\/mbe.2026052-4","doi-asserted-by":"publisher","unstructured":"C. Galassi, T. A. Chan, I. Vitale, L. Galluzzi, The hallmarks of cancer immune evasion, <i>Cancer Cell<\/i>, <b>42<\/b> (2024), 1825\u20131863. https:\/\/doi.org\/10.1016\/j.ccell.2024.09.010","DOI":"10.1016\/j.ccell.2024.09.010"},{"key":"key-10.3934\/mbe.2026052-5","doi-asserted-by":"publisher","unstructured":"A. Kashyap, M. A. Rapsomaniki, V. Barros, A. Fomitcheva-Khartchenko, A. L. Martinelli, A. F. Rodriguez, et al., Quantification of tumor heterogeneity: From data acquisition to metric generation, <i>Trends Biotechnol.<\/i>, <b>40<\/b> (2022), 647\u2013676. https:\/\/doi.org\/10.1016\/j.tibtech.2021.11.006","DOI":"10.1016\/j.tibtech.2021.11.006"},{"key":"key-10.3934\/mbe.2026052-6","doi-asserted-by":"publisher","unstructured":"J. Hausser, U. Alon, Tumour heterogeneity and the evolutionary trade-offs of cancer, <i>Nat. Rev. Cancer<\/i>, <b>20<\/b> (2020), 247\u2013257. https:\/\/doi.org\/10.1038\/s41568-020-0241-6","DOI":"10.1038\/s41568-020-0241-6"},{"key":"key-10.3934\/mbe.2026052-7","doi-asserted-by":"publisher","unstructured":"S. Turajlic, A. Sottoriva, T. Graham, C. Swanton, Resolving genetic heterogeneity in cancer, <i>Nat. Rev. Genet.<\/i>, <b>20<\/b> (2019), 404\u2013416. https:\/\/doi.org\/10.1038\/s41576-019-0114-6","DOI":"10.1038\/s41576-019-0114-6"},{"key":"key-10.3934\/mbe.2026052-8","doi-asserted-by":"publisher","unstructured":"R. A. Gatenby, J. S. Brown, Integrating evolutionary dynamics into cancer therapy, <i>Nat. Rev. Clin. Oncol.<\/i>, <b>17<\/b> (2020), 675\u2013686. https:\/\/doi.org\/10.1038\/s41571-020-0411-1","DOI":"10.1038\/s41571-020-0411-1"},{"key":"key-10.3934\/mbe.2026052-9","doi-asserted-by":"publisher","unstructured":"J. C. Marine, S. J. Dawson, M. A. Dawson, Non-genetic mechanisms of therapeutic resistance in cancer, <i>Nat. Rev. Cancer<\/i>, <b>20<\/b> (2020), 743\u2013756. https:\/\/doi.org\/10.1038\/s41568-020-00302-4","DOI":"10.1038\/s41568-020-00302-4"},{"key":"key-10.3934\/mbe.2026052-10","doi-asserted-by":"publisher","unstructured":"N. Vasan, J. Baselga, D. M. Hyman, A view on drug resistance in cancer, <i>Nature<\/i>, <b>575<\/b> (2019), 299\u2013309. https:\/\/doi.org\/10.1038\/s41586-019-1730-1","DOI":"10.1038\/s41586-019-1730-1"},{"key":"key-10.3934\/mbe.2026052-11","doi-asserted-by":"publisher","unstructured":"Z. D. Shi, K. Pang, Z. X. Wu, Y. Dong, L. Hao, J. X. Qin, et al., Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies, <i>Sig. Transduct. Target. Ther.<\/i>, <b>8<\/b> (2023), 113. https:\/\/doi.org\/10.1038\/s41392-023-01383-x","DOI":"10.1038\/s41392-023-01383-x"},{"key":"key-10.3934\/mbe.2026052-12","doi-asserted-by":"publisher","unstructured":"G. Albi, R. Chignola, F. Ferrarese, Efficient ensemble stochastic algorithms for agent-based models with spatial predator\u2013prey dynamics, <i>Math. Comput. Simul.<\/i>, <b>199<\/b> (2022), 317\u2013340. https:\/\/doi.org\/10.1016\/j.matcom.2022.03.019","DOI":"10.1016\/j.matcom.2022.03.019"},{"key":"key-10.3934\/mbe.2026052-13","doi-asserted-by":"publisher","unstructured":"J. Metzcar, Y. Wang, R. Heiland, P. Macklin, A review of cell-based computational modeling in cancer biology, <i>JCO Clin. Cancer Inf.<\/i>, <b>3<\/b> (2019), 1\u201313. https:\/\/doi.org\/10.1200\/CCI.18.00069","DOI":"10.1200\/CCI.18.00069"},{"key":"key-10.3934\/mbe.2026052-14","doi-asserted-by":"publisher","unstructured":"E. Merelli, G. Armano, N. Cannata, F. Corradini, M. d'Inverno, A. Doms, et al., Agents in bioinformatics, computational and systems biology, <i>Briefings Bioinf.<\/i>, <b>8<\/b> (2007), 45\u201359. https:\/\/doi.org\/10.1093\/bib\/bbl014","DOI":"10.1093\/bib\/bbl014"},{"key":"key-10.3934\/mbe.2026052-15","doi-asserted-by":"publisher","unstructured":"L. Zhang, Z. Wang, J. A. Sagotsky, T. S. Deisboeck, Multiscale agent-based cancer modeling, <i>J. Math. Biol.<\/i>, <b>58<\/b> (2009), 545\u2013559. https:\/\/doi.org\/10.1007\/s00285-008-0211-1","DOI":"10.1007\/s00285-008-0211-1"},{"key":"key-10.3934\/mbe.2026052-16","doi-asserted-by":"publisher","unstructured":"M. N. G. van Genderen, J. Kneppers, A. Zaalberg, E. M. Bekers, A. M. Bergman, W. Zwart, et al., Agent-based modeling of the prostate tumor microenvironment uncovers spatial tumor growth constraints and immunomodulatory properties, <i>NPJ Syst. Biol. Appl.<\/i>, <b>10<\/b> (2024), 20. https:\/\/doi.org\/10.1038\/s41540-024-00344-6","DOI":"10.1038\/s41540-024-00344-6"},{"key":"key-10.3934\/mbe.2026052-17","doi-asserted-by":"publisher","unstructured":"A. R. Anderson, A. M. Weaver, P. T. Cummings, V. Quaranta, Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment, <i>Cell<\/i>, <b>127<\/b> (2006), 905\u2013915. https:\/\/doi.org\/10.1016\/j.cell.2006.09.042","DOI":"10.1016\/j.cell.2006.09.042"},{"key":"key-10.3934\/mbe.2026052-18","doi-asserted-by":"publisher","unstructured":"L. Zhang, L. L. Chen, T. S. Deisboeck, Multi-scale, multi-resolution brain cancer modeling, <i>Math. Comput. Simul.<\/i>, <b>79<\/b> (2009), 2021\u20132035. https:\/\/doi.org\/10.1016\/j.matcom.2008.09.007","DOI":"10.1016\/j.matcom.2008.09.007"},{"key":"key-10.3934\/mbe.2026052-19","doi-asserted-by":"publisher","unstructured":"G. Stamatakos, D. Dionysiou, A. Lunzer, R. Belleman, E. Kolokotroni, E. Georgiadi, et al., The technologically integrated oncosimulator: Combining multiscale cancer modeling with information technology in the in silico oncology context, <i>IEEE J. Biomed. Health Inf.<\/i>, <b>18<\/b> (2014), 840\u2013854. https:\/\/doi.org\/10.1109\/JBHI.2013.2284276","DOI":"10.1109\/JBHI.2013.2284276"},{"key":"key-10.3934\/mbe.2026052-20","doi-asserted-by":"publisher","unstructured":"C. Gong, O. Milberg, B. Wang, P. Vicini, R. Narwal, L. Roskos, et al., A computational multiscale agent-based model for simulating spatio-temporal tumour immune response to PD1 and PDL1 inhibition, <i>J. R. Soc. Interface<\/i>, <b>14<\/b> (2017), 20170320. https:\/\/doi.org\/10.1587\/elex.14.20170320","DOI":"10.1587\/elex.14.20170320"},{"key":"key-10.3934\/mbe.2026052-21","doi-asserted-by":"publisher","unstructured":"A. Jalalimanesh, H. S. Haghighi, A. Ahmadi, M. Soltani, Simulation-based optimization of radiotherapy: Agent-based modeling and reinforcement learning, <i>Math. Comput. Simul.<\/i>, <b>133<\/b> (2017), 235\u2013248. https:\/\/doi.org\/10.1016\/j.matcom.2016.05.008","DOI":"10.1016\/j.matcom.2016.05.008"},{"key":"key-10.3934\/mbe.2026052-22","doi-asserted-by":"publisher","unstructured":"J. U. Legaria-Pe\u00f1a, F. S\u00e1nchez-Morales, Y. Cort\u00e9s-Poza, Evaluation of entropy and fractal dimension as biomarkers for tumor growth and treatment response using cellular automata, <i>J. Theor. Biol.<\/i>, <b>564<\/b> (2023), 111462. https:\/\/doi.org\/10.1016\/j.jtbi.2023.111462","DOI":"10.1016\/j.jtbi.2023.111462"},{"key":"key-10.3934\/mbe.2026052-23","doi-asserted-by":"publisher","unstructured":"J. U. Legaria-Pe\u00f1a, F. S\u00e1nchez-Morales, Y. Cort\u00e9s-Poza, Understanding post-angiogenic tumor growth: Insights from vascular network properties in cellular automata modeling, <i>Chaos, Solitons Fractals<\/i>, <b>186<\/b> (2024), 115199. https:\/\/doi.org\/10.1016\/j.chaos.2024.115199","DOI":"10.1016\/j.chaos.2024.115199"},{"key":"key-10.3934\/mbe.2026052-24","doi-asserted-by":"publisher","unstructured":"J. U. Legaria-Pe\u00f1a, F. S\u00e1nchez-Morales, Y. Cort\u00e9s-Poza, Study of the interplay between cancer, inflammation, and immune disorders: A cellular automaton approach, <i>Appl. Math. Model.<\/i>, <b>150<\/b> (2026), 116315. https:\/\/doi.org\/10.1016\/j.apm.2025.116315","DOI":"10.1016\/j.apm.2025.116315"},{"key":"key-10.3934\/mbe.2026052-25","doi-asserted-by":"publisher","unstructured":"A. Surendran, A. L. Jenner, E. Karimi, B. Fiset, D. F. Quail, L. A. Walsh, et al., Agent-based modelling reveals the role of the tumor microenvironment on the short-term success of combination temozolomide\/immune checkpoint blockade to treat glioblastoma, <i>J. Pharmacol. Exp. Ther.<\/i>, <b>387<\/b> (2023), 66\u201377. https:\/\/doi.org\/10.1124\/jpet.122.001571","DOI":"10.1124\/jpet.122.001571"},{"key":"key-10.3934\/mbe.2026052-26","doi-asserted-by":"publisher","unstructured":"B. Mongeon, J. H\u00e9bert-Doutreloux, A. Surendran, E. Karimi, B. Fiset, D. F. Quail, et al., Spatial computational modelling illuminates the role of the tumour microenvironment for treating glioblastoma with immunotherapies, <i>NPJ Syst. Biol. Appl.<\/i>, <b>10<\/b> (2024), 91. https:\/\/doi.org\/10.1038\/s41540-024-00419-4","DOI":"10.1038\/s41540-024-00419-4"},{"key":"key-10.3934\/mbe.2026052-27","doi-asserted-by":"publisher","unstructured":"J. West, M. Robertson-Tessi, A. R. Anderson, Agent-based methods facilitate integrative science in cancer, <i>Trends Cell Biol.<\/i>, <b>33<\/b> (2023), 300\u2013311. https:\/\/doi.org\/10.1016\/j.tcb.2022.10.006","DOI":"10.1016\/j.tcb.2022.10.006"},{"key":"key-10.3934\/mbe.2026052-28","doi-asserted-by":"publisher","unstructured":"D. Hanahan, R. A. Weinberg, The hallmarks of cancer, <i>Cell<\/i>, <b>100<\/b> (2000), 57\u201370. https:\/\/doi.org\/10.1016\/S0092-8674(00)81683-9","DOI":"10.1016\/S0092-8674(00)81683-9"},{"key":"key-10.3934\/mbe.2026052-29","doi-asserted-by":"publisher","unstructured":"D. Hanahan, R. A. Weinberg, Hallmarks of cancer: The next generation, <i>Cell<\/i>, <b>144<\/b> (2011), 646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"key-10.3934\/mbe.2026052-30","doi-asserted-by":"publisher","unstructured":"D. Hanahan, Hallmarks of cancer: New dimensions, <i>Cancer Discov.<\/i>, <b>12<\/b> (2022), 31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059","DOI":"10.1158\/2159-8290.CD-21-1059"},{"key":"key-10.3934\/mbe.2026052-31","doi-asserted-by":"publisher","unstructured":"H. Raskov, A. Orhan, J. P. Christensen, I. G\u00f6genur, Cytotoxic CD8+ T cells in cancer and cancer immunotherapy, <i>Br. J. Cancer<\/i>, <b>124<\/b> (2020), 359\u2013367. https:\/\/doi.org\/10.1038\/s41416-020-01048-4","DOI":"10.1038\/s41416-020-01048-4"},{"key":"key-10.3934\/mbe.2026052-32","doi-asserted-by":"publisher","unstructured":"M. Philip, A. Schietinger, CD8+ T cell differentiation and dysfunction in cancer, <i>Nat. Rev. Immunol.<\/i>, <b>22<\/b> (2021), 209\u2013223. https:\/\/doi.org\/10.1057\/s41260-021-00210-8","DOI":"10.1057\/s41260-021-00210-8"},{"key":"key-10.3934\/mbe.2026052-33","doi-asserted-by":"publisher","unstructured":"J. R. Giles, A. M. Globig, S. M. Kaech, E. J. Wherry, CD8+ T cells in the cancer-immunity cycle, <i>Immunity<\/i>, <b>56<\/b> (2023), 2231\u20132253. https:\/\/doi.org\/10.1016\/j.immuni.2023.09.005","DOI":"10.1016\/j.immuni.2023.09.005"},{"key":"key-10.3934\/mbe.2026052-34","doi-asserted-by":"publisher","unstructured":"Z. Vasconcelos, S. M\u00fcller, D. Guipouy, W. Yu, C. Christophe, S. Gadat, et al., Individual human cytotoxic T lymphocytes exhibit intraclonal heterogeneity during sustained killing, <i>Cell Rep.<\/i>, <b>11<\/b> (2015), 1474\u20131485. https:\/\/doi.org\/10.1016\/j.celrep.2015.05.002","DOI":"10.1016\/j.celrep.2015.05.002"},{"key":"key-10.3934\/mbe.2026052-35","doi-asserted-by":"publisher","unstructured":"R. Khazen, M. Cazaux, F. Lema\u00eftre, B. Corre, Z. Garcia, P. Bousso, Functional heterogeneity of cytotoxic T cells and tumor resistance to cytotoxic hits limit anti\u2010tumor activity <i>in vivo<\/i>, <i>EMBO J.<\/i>, <b>40<\/b> (2021), e106658. https:\/\/doi.org\/10.15252\/embj.2020106658","DOI":"10.15252\/embj.2020106658"},{"key":"key-10.3934\/mbe.2026052-36","doi-asserted-by":"publisher","unstructured":"D. H. Raulet, M. J. Bevan, A differentiation factor required for the expression of cytotoxic T-cell function, <i>Nature<\/i>, <b>296<\/b> (1982), 754\u2013757. https:\/\/doi.org\/10.1038\/296754a0","DOI":"10.1038\/296754a0"},{"key":"key-10.3934\/mbe.2026052-37","doi-asserted-by":"publisher","unstructured":"F. Y. Liew, Th1 and Th2 cells: A historical perspective, <i>Nat. Rev. Immunol.<\/i>, <b>2<\/b> (2002), 55\u201360. https:\/\/doi.org\/10.1038\/nri705","DOI":"10.1038\/nri705"},{"key":"key-10.3934\/mbe.2026052-38","doi-asserted-by":"publisher","unstructured":"R. Spolski, P. Li, W. J. Leonard, Biology and regulation of IL-2: From molecular mechanisms to human therapy, <i>Nat. Rev. Immunol.<\/i>, <b>18<\/b> (2018), 648\u2013659. https:\/\/doi.org\/10.1038\/s41577-018-0046-y","DOI":"10.1038\/s41577-018-0046-y"},{"key":"key-10.3934\/mbe.2026052-39","doi-asserted-by":"publisher","unstructured":"T. Okazaki, S. Chikuma, Y. Iwai, S. Fagarasan, T. Honjo, A rheostat for immune responses: The unique properties of PD-1 and their advantages for clinical application, <i>Nat. Immunol.<\/i>, <b>14<\/b> (2013), 1212\u20131218. https:\/\/doi.org\/10.1038\/ni.2762","DOI":"10.1038\/ni.2762"},{"key":"key-10.3934\/mbe.2026052-40","doi-asserted-by":"publisher","unstructured":"N. Patsoukis, Q. Wang, L. Strauss, V. A. Boussiotis, Revisiting the PD-1 pathway, <i>Sci. Adv.<\/i>, <b>6<\/b> (2020), eabd2712. https:\/\/doi.org\/10.1126\/sciadv.abd2712","DOI":"10.1126\/sciadv.abd2712"},{"key":"key-10.3934\/mbe.2026052-41","doi-asserted-by":"publisher","unstructured":"W. Zou, Regulatory T cells, tumour immunity and immunotherapy, <i>Nat. Rev. Immunol.<\/i>, <b>6<\/b> (2006), 295\u2013307. https:\/\/doi.org\/10.1038\/nri1806","DOI":"10.1038\/nri1806"},{"key":"key-10.3934\/mbe.2026052-42","doi-asserted-by":"publisher","unstructured":"A. Facciabene, G. T. Motz, G. Coukos, T-regulatory cells: Key players in tumor immune escape and angiogenesis, <i>Cancer Res.<\/i>, <b>72<\/b> (2012), 2162\u20132171. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3687","DOI":"10.1158\/0008-5472.CAN-11-3687"},{"key":"key-10.3934\/mbe.2026052-43","doi-asserted-by":"publisher","unstructured":"Y. Togashi, K. Shitara, H. Nishikawa, Regulatory T cells in cancer immunosuppression\u2014implications for anticancer therapy, <i>Nat. Rev. Clin. Oncol.<\/i>, <b>16<\/b> (2019), 356\u2013371. https:\/\/doi.org\/10.1038\/s41571-019-0175-7","DOI":"10.1038\/s41571-019-0175-7"},{"key":"key-10.3934\/mbe.2026052-44","doi-asserted-by":"publisher","unstructured":"C. J. Imianowski, Q. Chen, C. J. Workman, D. A. A. Vignali, Regulatory T cells in the tumour microenvironment, <i>Nat. Rev. Cancer<\/i>, <b>25<\/b> (2025), 703\u2013722. https:\/\/doi.org\/10.1038\/s41568-025-00832-9","DOI":"10.1038\/s41568-025-00832-9"},{"key":"key-10.3934\/mbe.2026052-45","doi-asserted-by":"publisher","unstructured":"L. Zhou, M. M. Chong, D. R. Littman, Plasticity of CD4+ T cell lineage differentiation, <i>Immunity<\/i>, <b>30<\/b> (2009), 646\u2013655. https:\/\/doi.org\/10.1016\/j.immuni.2009.05.001","DOI":"10.1016\/j.immuni.2009.05.001"},{"key":"key-10.3934\/mbe.2026052-46","doi-asserted-by":"publisher","unstructured":"A. J. Ozga, M. T. Chow, A. D. Luster, Chemokines and the immune response to cancer, <i>Immunity<\/i>, <b>54<\/b> (2021), 859\u2013874. https:\/\/doi.org\/10.1016\/j.immuni.2021.01.012.","DOI":"10.1016\/j.immuni.2021.01.012"},{"key":"key-10.3934\/mbe.2026052-47","doi-asserted-by":"publisher","unstructured":"N. Nagarsheth, M. S. Wicha, W. Zou, Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy, <i>Nat. Rev. Immunol.<\/i>, <b>17<\/b> (2017), 559\u2013572. https:\/\/doi.org\/10.1038\/nri.2017.49","DOI":"10.1038\/nri.2017.49"},{"key":"key-10.3934\/mbe.2026052-48","doi-asserted-by":"publisher","unstructured":"J. A. Joyce, D. T. Fearon, T cell exclusion, immune privilege, and the tumor microenvironment, <i>Science<\/i>, <b>348<\/b> (2015), 74\u201380. https:\/\/doi.org\/10.1126\/science.aaa6204","DOI":"10.1126\/science.aaa6204"},{"key":"key-10.3934\/mbe.2026052-49","doi-asserted-by":"publisher","unstructured":"D. De Ruysscher, G. Niedermann, N. G. Burnet, S. Siva, A. W. M. Lee, F. Hegi-Johnson, Radiotherapy toxicity, <i>Nat. Rev. Dis. Primers<\/i>, <b>5<\/b> (2019), 13. https:\/\/doi.org\/10.1038\/s41572-019-0068-1","DOI":"10.1038\/s41572-019-0068-1"},{"key":"key-10.3934\/mbe.2026052-50","doi-asserted-by":"publisher","unstructured":"R. A. Chandra, F. K. Keane, F. E. M. Voncken, C. R. J. Thomas, Contemporary radiotherapy: Present and future, <i>Lancet<\/i>, <b>398<\/b> (2021), 171\u2013184. https:\/\/doi.org\/10.1016\/S0140-6736(21)00233-6","DOI":"10.1016\/S0140-6736(21)00233-6"},{"key":"key-10.3934\/mbe.2026052-51","doi-asserted-by":"publisher","unstructured":"A. C. Begg, F. A. Stewart, C. Vens, Strategies to improve radiotherapy with targeted drugs, <i>Nat. Rev. Cancer<\/i>, <b>11<\/b> (2011), 239\u2013253. https:\/\/doi.org\/10.1038\/nrc3007","DOI":"10.1038\/nrc3007"},{"key":"key-10.3934\/mbe.2026052-52","doi-asserted-by":"publisher","unstructured":"H. E. Barker, J. T. E. Paget, A. A. Khan, K. J. Harrington, The tumour microenvironment after radiotherapy: Mechanisms of resistance and recurrence, <i>Nat. Rev. Cancer<\/i>, <b>15<\/b> (2015), 409\u2013425. https:\/\/doi.org\/10.1038\/nrc3958","DOI":"10.1038\/nrc3958"},{"key":"key-10.3934\/mbe.2026052-53","doi-asserted-by":"publisher","unstructured":"H. Y. Choi, J. E. Chang, Targeted therapy for cancers: From ongoing clinical trials to FDA-approved drugs, <i>Int. J. Mol. Sci.<\/i>, <b>24<\/b> (2023), 13618. https:\/\/doi.org\/10.3390\/ijms241713618","DOI":"10.3390\/ijms241713618"},{"key":"key-10.3934\/mbe.2026052-54","doi-asserted-by":"publisher","unstructured":"P. Ramos, M. Bentires-Alj, Mechanism-based cancer therapy: Resistance to therapy, therapy for resistance, <i>Oncogene<\/i>, <b>34<\/b> (2014), 3617\u20133626. https:\/\/doi.org\/10.1038\/onc.2014.314","DOI":"10.1038\/onc.2014.314"},{"key":"key-10.3934\/mbe.2026052-55","doi-asserted-by":"publisher","unstructured":"C. Sun, R. Mezzadra, T. N. Schumacher, Regulation and function of the PD-L1 checkpoint, <i>Immunity<\/i>, <b>48<\/b> (2018), 434\u2013452. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.014","DOI":"10.1016\/j.immuni.2018.03.014"},{"key":"key-10.3934\/mbe.2026052-56","doi-asserted-by":"publisher","unstructured":"C. Zhang, C. Shao, X. Jian, Y. Bai, M. Li, H. Shi, et al., Individual cell-based modeling of tumor cell plasticity-induced immune escape after CAR-T therapy, <i>Comput. Syst. Oncol.<\/i>, <b>1<\/b> (2021), e21029. https:\/\/doi.org\/10.1002\/cso2.1029","DOI":"10.1002\/cso2.1029"},{"key":"key-10.3934\/mbe.2026052-57","doi-asserted-by":"publisher","unstructured":"S. V. Sharma, D. Y. Lee, B. Li, M. P. Quinlan, F. Takahashi, S. Maheswaran, et al., A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations, <i>Cell<\/i>, <b>141<\/b> (2010), 69\u201380. https:\/\/doi.org\/10.1016\/j.cell.2010.02.027","DOI":"10.1016\/j.cell.2010.02.027"},{"key":"key-10.3934\/mbe.2026052-58","doi-asserted-by":"crossref","unstructured":"E. Eisenhauer, P. Therasse, J. Bogaerts, L. Schwartz, D. Sargent, R. Ford, et al., New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1), <i>Eur. J. Cancer<\/i>, <b>45<\/b> (2009), 228\u2013247.","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"key-10.3934\/mbe.2026052-59","doi-asserted-by":"publisher","unstructured":"J. W. Hickey, E. Agmon, N. Horowitz, T. K. Tan, M. Lamore, J. B. Sunwoo, et al., Integrating multiplexed imaging and multiscale modeling identifies tumor phenotype conversion as a critical component of therapeutic T cell efficacy, <i>Cell Syst.<\/i>, <b>15<\/b> (2024), 322\u2013338.e5. https:\/\/doi.org\/10.1016\/j.cels.2024.03.004","DOI":"10.1016\/j.cels.2024.03.004"},{"key":"key-10.3934\/mbe.2026052-60","doi-asserted-by":"publisher","unstructured":"W. Xu, R. Mezencev, B. Kim, L. Wang, J. McDonald, T. Sulchek, Cell stiffness is a biomarker of the metastatic potential of ovarian cancer cells, <i>PLoS One<\/i>, <b>7<\/b> (2012), e46609. https:\/\/doi.org\/10.1371\/journal.pone.0046609","DOI":"10.1371\/journal.pone.0046609"},{"key":"key-10.3934\/mbe.2026052-61","doi-asserted-by":"publisher","unstructured":"M. Najafi, B. Farhood, K. Mortezaee, Extracellular matrix (ECM) stiffness and degradation as cancer drivers, <i>J. Cell Biochem.<\/i>, <b>120<\/b> (2018), 2782\u20132790. https:\/\/doi.org\/10.1002\/jcb.27681","DOI":"10.1002\/jcb.27681"},{"key":"key-10.3934\/mbe.2026052-62","doi-asserted-by":"publisher","unstructured":"C. Borau, R. Chisholm, P. Richmond, D. Walker, An agent-based model for cell microenvironment simulation using FLAMEGPU2, <i>Comput. Biol. Med.<\/i>, <b>179<\/b> (2024), 108831. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108831","DOI":"10.1016\/j.compbiomed.2024.108831"}],"container-title":["Mathematical Biosciences and Engineering"],"original-title":[],"link":[{"URL":"http:\/\/www.aimspress.com\/article\/doi\/10.3934\/mbe.2026052?viewType=html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T10:37:57Z","timestamp":1776076677000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aimspress.com\/article\/doi\/10.3934\/mbe.2026052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3934\/mbe.2026052","relation":{},"ISSN":["1551-0018"],"issn-type":[{"value":"1551-0018","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}